[1]
Rovik, A., Setiawan, V.K., Daniwijaya, E.W. and Puspita, R.D. 2026. MET-Mediated Drug Resistance in Colorectal Cancer: In Silico Analysis of the Potential of Epicatechin-3-Gallate and Epigallocatechin-3-Gallate as Therapeutic Adjuvants. Integrated Health Research Journal. 3, (1-Supp) (Jun. 2026), 05–16. DOI:https://doi.org/10.47963/ihrj.v3i(1-Supp).2075.